The State Enterprise 'Medical Procurements' will begin producing innovative drugs for cancer treatment.
According to the press service of 'Medical Procurements' on Facebook, the agreement with the international pharmaceutical company Roche to localize the production of innovative cancer medications was signed at the Ukraine Recovery Conference 2025 in Rome.
'For the first time, our state enterprise is becoming a full-fledged partner of a global leader in innovative drug development! Under the investment agreement, the Swiss international company Roche will supply pharmaceutical products to Ukraine in bulk - that is, ready for packaging. Our branch 'Medpostachannya' will carry out the final packaging, labeling, and delivery to patients,' the statement noted.
This will significantly reduce the cost of the medications and increase the number of patients receiving modern treatment.
'According to Roche's estimates, over the next five years, the signed investment agreement will provide drugs for more than 5,800 patients,' they stated at 'Medical Procurements.'
Specifically, they will procure drugs for the two most common types of cancer in Ukraine:
- Atezolizumab ('Tecentriq') - for the treatment of non-small cell lung cancer;
- Pertuzumab + Trastuzumab ('Phesgo') - for the treatment of HER2-positive breast cancer.
Ukrainian patients will be able to receive drugs from localized production as early as 2027.
This collaboration allows for significant cost reductions for medicines, the development of pharmaceutical manufacturing in Ukraine, and stable access to treatment.
On July 10-11, the fourth International Conference on Ukraine Recovery (URC2025) is taking place in Rome, attended by the President of Ukraine and heads of European states.
The forum will continue a series of high-level political events dedicated to the rapid recovery and long-term reconstruction of Ukraine, which is suffering from external aggression. This time, the Ukrainian delegation will focus on presenting practical projects that are already being implemented even in war conditions or are highly prepared for implementation.